Alcohol use and consequences in matriculating US college students by prescription stimulant/opioid nonmedical misuse status.


Journal

Addictive behaviors
ISSN: 1873-6327
Titre abrégé: Addict Behav
Pays: England
ID NLM: 7603486

Informations de publication

Date de publication:
11 2019
Historique:
received: 05 04 2019
revised: 15 06 2019
accepted: 17 06 2019
pubmed: 16 8 2019
medline: 29 10 2020
entrez: 16 8 2019
Statut: ppublish

Résumé

US college students have elevated prescription opioid and stimulant misuse rates, with frequent alcohol use and alcohol-related consequences (ARCs). To date, though, no research has examined relationships between opioid and/or stimulant misuse and alcohol quantity/frequency or ARC variables in college students. The 2016-17 AlcoholEDU for College™, a web-based alcohol prevention program, provided data (n = 491,849). Participants were grouped into past 14-day: (1) no misuse; (2) opioid misuse only; (3) stimulant misuse only; and (4) combined misuse. Using multilevel logistic regressions, groups were compared on 14-day alcohol use odds, and among those with use, odds of any ARCs and specific ARCs (e.g., hangover). Multilevel negative binomial regressions compared group members with alcohol use on 14-day total drinks, maximum 24-h drinks and drinking days. Alcohol use and any ARCs odds were highest in the stimulant (odds ratios [OR] = 3.47 and 2.97, respectively) or opioid misuse only groups (ORs = 3.31 and 2.43, respectively), with the combined misuse group intermediate (ORs = 1.63 and 1.29; reference: no misuse). Mean 14-day drinks decreased from those with combined misuse, to those with stimulant misuse only, opioid misuse only and no misuse (8.22, 7.1, 6.67, and 4.71, respectively). College students engaged in 14-day stimulant and/or opioid misuse had higher odds of 14-day alcohol use, higher levels of alcohol use, and a greater likelihood of ARCs, versus students without misuse. These findings suggest that college students with any prescription misuse need alcohol screening, although those with poly-prescription misuse may not need more intensive alcohol interventions.

Sections du résumé

BACKGROUND
US college students have elevated prescription opioid and stimulant misuse rates, with frequent alcohol use and alcohol-related consequences (ARCs). To date, though, no research has examined relationships between opioid and/or stimulant misuse and alcohol quantity/frequency or ARC variables in college students.
METHODS
The 2016-17 AlcoholEDU for College™, a web-based alcohol prevention program, provided data (n = 491,849). Participants were grouped into past 14-day: (1) no misuse; (2) opioid misuse only; (3) stimulant misuse only; and (4) combined misuse. Using multilevel logistic regressions, groups were compared on 14-day alcohol use odds, and among those with use, odds of any ARCs and specific ARCs (e.g., hangover). Multilevel negative binomial regressions compared group members with alcohol use on 14-day total drinks, maximum 24-h drinks and drinking days.
RESULTS
Alcohol use and any ARCs odds were highest in the stimulant (odds ratios [OR] = 3.47 and 2.97, respectively) or opioid misuse only groups (ORs = 3.31 and 2.43, respectively), with the combined misuse group intermediate (ORs = 1.63 and 1.29; reference: no misuse). Mean 14-day drinks decreased from those with combined misuse, to those with stimulant misuse only, opioid misuse only and no misuse (8.22, 7.1, 6.67, and 4.71, respectively).
CONCLUSIONS
College students engaged in 14-day stimulant and/or opioid misuse had higher odds of 14-day alcohol use, higher levels of alcohol use, and a greater likelihood of ARCs, versus students without misuse. These findings suggest that college students with any prescription misuse need alcohol screening, although those with poly-prescription misuse may not need more intensive alcohol interventions.

Identifiants

pubmed: 31415970
pii: S0306-4603(19)30411-3
doi: 10.1016/j.addbeh.2019.06.015
pmc: PMC6754780
mid: NIHMS1537131
pii:
doi:

Substances chimiques

Analgesics, Opioid 0
Central Nervous System Stimulants 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

106026

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA043691
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA019925
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Références

J Am Coll Health. 2000 Mar;48(5):199-210
pubmed: 10778020
J Stud Alcohol Suppl. 2002 Mar;(14):54-70
pubmed: 12022730
J Am Coll Health. 2002 Nov;51(3):117-9, 122-31
pubmed: 12638993
Eur J Clin Nutr. 2004 Jan;58(1):60-3
pubmed: 14679368
Am J Drug Alcohol Abuse. 2004;30(1):205-24
pubmed: 15083562
Addict Behav. 2004 Jul;29(5):959-63
pubmed: 15219342
Drug Alcohol Depend. 2005 Jan 7;77(1):37-47
pubmed: 15607840
J Am Acad Child Adolesc Psychiatry. 2008 Jul;47(7):745-754
pubmed: 18520963
J Atten Disord. 2009 Sep;13(2):144-53
pubmed: 19448150
Am J Epidemiol. 2010 Jan 1;171(1):93-104
pubmed: 19969527
J Stud Alcohol. 1990 Sep;51(5):389-95
pubmed: 2232790
Subst Use Misuse. 2013 Dec;48(14):1463-8
pubmed: 23750616
Adolesc Med State Art Rev. 2013 Dec;24(3):597-610
pubmed: 24654550
Addict Behav. 2014 Dec;39(12):1798-803
pubmed: 25123349
Drug Alcohol Rev. 2015 Mar;34(2):211-20
pubmed: 25196636
Soc Psychiatry Psychiatr Epidemiol. 2015 May;50(5):713-24
pubmed: 25427665
Clin Child Fam Psychol Rev. 2015 Mar;18(1):50-76
pubmed: 25575768
Addict Behav. 2018 Jan;76:27-33
pubmed: 28735038
Drug Alcohol Depend. 2018 Feb 1;183:73-77
pubmed: 29241103
Pharmacoepidemiol Drug Saf. 2018 May;27(5):464-472
pubmed: 29243305
J Stud Alcohol. 1989 Jan;50(1):30-7
pubmed: 2927120
Drug Alcohol Depend. 2018 Aug 1;189:172-177
pubmed: 29960204
Addict Behav. 2018 Dec;87:122-130
pubmed: 30005334
Int J Geriatr Psychiatry. 2019 Jan;34(1):122-129
pubmed: 30328160
Int J Addict. 1983 Aug;18(6):805-24
pubmed: 6605313
Drug Alcohol Depend. 1983 Jun;11(3-4):249-69
pubmed: 6617465

Auteurs

Ty S Schepis (TS)

Department of Psychology, Texas State University, San Marcos, TX, USA. Electronic address: schepis@txstate.edu.

Shawn Acheson (S)

Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA.

Daniel Zapp (D)

EverFi, Washington, DC, USA.

H Scott Swartzwelder (HS)

Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH